iSOFT collaborates with Intel and Motion Computing on launch of Mobile Clinical Assistant

iSOFTFollowing months of development and collaboration, iSOFT has announced its intention to support its customers in their adoption of the Mobile Clinical Assistant (MCA). The platform, announced earlier by Intel Corporation and Motion Computing, will allow clinicians to spend more time with patients, help improve patient safety and reduce medication administration errors. Motion Computing's C5 is the first product based on Intel's platform and has earned support from clinicians and nurses participating in pilot studies conducted around the world.

In the UK trial at Salford Royal NHS Foundation Trust, phlebotomists and nurses used iSOFT's i.Clinical Manager (i.CM) on MCA devices. The project at Salford Royal was primarily to understand precisely how the MCA would be used in practice by clinical staff when it is integrated with actual medical and business processes.

Fifteen MCAs loaded with iSOFT's i.CM were used in a trial at Salford Royal. The ability to view and record clinical details at the point of care was found to improve the quality of information and efficiency of clinicians. Access to information in real-time proved particularly beneficial to phlebotomists as it prevented blood samples being taken unnecessarily and the need for duplicate tests. Salford Royal is an existing user of iSOFT's i.CM clinical software application as well as other iSOFT applications for patient administration, accident and emergency, and laboratory information systems.

"As a leading EMR provider, iSOFT is a natural choice for MCA trial collaboration," said Louis Burns, vice president and general manager, Intel's Digital Health Group. "We have enjoyed working closely with iSOFT, Motion, the NHS and the nurses at Salford Royal to develop a technology solution that truly serves the needs of healthcare professionals in clinical settings."

"Historically, one of the reasons EMR implementations have been only moderately successful is that independent vendors of hardware, software and infrastructure did not collaborate early enough in the solution design lifecycle," said Nigel Owens, Motion general manager of EMEA. "That's why iSOFT's work here is important. Its work with Motion and Intel will continue to help improve clinician experiences with the Motion C5 MCA."

Bill Henry, iSOFT's chief operating officer, said: "MCA is a major advance in mobile healthcare computing and finally puts computer technology into care environments safely. Having real-time clinical information to support decisions at the point of care while also minimising the risk of infection, is a huge benefit to clinical staff and patients alike. To improve the quality of healthcare and staff workflow, it is vital to have accurate and up-to-date information at the point of decision, whether on a ward or in a surgical department.

"Our collaboration with Intel and Motion, in the only clinician usability and field trial within the NHS using the Motion C5 MCA, is a testament to our standing as a world-class provider of clinical applications such as i.CM."

Henry added: "This technology offers significant opportunities for iSOFT and its customers and we will continue to work with Intel and Motion in helping to develop this set of products. We remain committed to supporting our customers in the delivery of better healthcare through the combination of our leading software and technology from partners such as Motion and Intel."

iSOFT has a long-standing commitment to mobile technology. The company was selected as Microsoft's exclusive European software partner for the launch of its tablet PC in 2002.

Related news articles:

iSOFT is Europe's largest healthcare software applications company and also has a strong presence and experience in the Asia Pacific region. Its core strategic application, LORENZO, is at the forefront of the technology revolution taking place in healthcare globally. iSOFT products are used to manage patient information in more than 8,000 organisations in 27 countries. With annual revenues of £180 million, the company has offices in 12 countries and more than 3,000 employees, over 1,400 of whom are engaged in software development and design. Further information: http://www.isoftplc.com.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...